UK: Foundation approvals on hold as industry awaits review report
This article was originally published in Clinica
This month saw another six UK National Health Service trusts gain foundation status, bringing the total to 31. The government remains committed to ensuring that all trusts - some 300 - will be eligible to apply for foundation status by 2008, but in their way stand significant commercial and tariff-related problems. While some have surfaced in the form of serious financial management issues for the new foundation trusts themselves, the issues also have significant repercussions for the medical technology industry (see Clinica No 1150, p 7).
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.